High efficacy and safety of CD38 and BCMA bispecific CAR-T in relapsed or refractory multiple myeloma

Authors: Yuanyan Tang, Haisen Yin, Xinying Zhao, Dan Jin, Yan Liang, Tao Xiong, Lu Li, Wen Tang, Jiangzhao Zhang, Min Liu, Zhuojun Yu, Huimin Liu, Sibin Zang, Zhiping Huang

Published: 2022-01-03

DOI: 10.1186/s13046-021-02214-z

Source: Full article

High efficacy and safety of CD38 and BCMA bispecific CAR-T in relapsed or refractory multiple myeloma

Abstract